Buying safely
How to tell a licensed program from a bad one before you hand over a card.
The cheapest semaglutide we track today is $69/mo at SnagRx, checked October 2026. Every semaglutide price
Buying safelyHow to get Wegovy, online or in person: the criteria, the prescriber, the tablet, and what each route costsYou can get Wegovy online: any licensed prescriber can write it by video, and Novo's own NovoCare Pharmacy ships the pen or the daily tablet to your door. You qualify as an adult with obesity, or overweight plus a weight-related condition, or with heart disease. Paying is the variable: $25 with covered commercial insurance and Novo's card, $50 on Medicare's GLP-1 Bridge, $349 a month for the pen or from $149 for the tablet direct from Novo, and compounded semaglutide from $69 on our board.Buying safelyBuying a GLP-1 in Mexico or Canada: what the import rules say, where the fakes turn up, and the legal US price to beatFor most US buyers it is illegal to buy Ozempic, Wegovy, Mounjaro or a generic semaglutide in Mexico or Canada and bring or ship it home: FDA says a drug approved abroad but unapproved here is illegal to import, and CBP says the same at the border. Falsified Ozempic pens have been found in Mexico in 2026. A legal US prescription starts at $69 a month on our board.Buying safelySemaglutide online: the six versions you can be prescribed, what the rules now allow, and what each costsYou can get semaglutide online with a prescription from a telehealth clinician, and it comes in six versions: Novo Nordisk's Wegovy and Ozempic, each as a weekly pen or a daily pill, plus compounded injections and compounded oral forms made by pharmacies. Compounded semaglutide starts at $69 a month on our board. Novo sells its own brands for cash from $149 a month for a pill and $199 for a starter pen. Compounded versions are not FDA approved.Buying safelyHow to get Ozempic online: the prescription, the pen or the pill, and what each route costsYou can get Ozempic online, but only with a prescription, and a telehealth clinician can write one after a video or questionnaire visit. Ozempic is approved for type 2 diabetes, so a plan that covers it brings it to $25 a month with Novo's card. Without coverage, Novo's own pharmacy sells the pen from $199 for two starter fills, then $349 to $499, and the new Ozempic pill from $149. For weight loss alone, Wegovy or compounded semaglutide from $69 usually fits better.Buying safelyTelehealth weight loss programs: how they work, what the monthly price covers, and the red flagsA telehealth weight loss program is an online clinic: you fill in a health questionnaire, a licensed clinician reviews it and decides whether to prescribe a GLP-1, and a pharmacy ships it to your door. Cash prices on our board start at $69 a month for compounded semaglutide and $85 for compounded tirzepatide. What the headline leaves out is a membership fee, dose-based pricing or a prepaid term, so compare the all-in monthly figure.Buying safelyHow to get Zepbound: who qualifies, who prescribes it, and the four ways to payZepbound is a prescription drug approved for adults with obesity, or overweight with at least one weight-related condition, which the trials defined as a BMI of 30, or 27 with a comorbidity. Any licensed prescriber can write it, including online. Then it is a payment question with four answers: a commercial plan that covers it brings it to $25 with Lilly's card; Lilly sells it direct for $299 to $699 a month by dose; a plan that refuses can be appealed; and compounded tirzepatide, the same molecule without FDA approval, starts at $85 on our board.Buying safelyHow to get Mounjaro: the diabetes route, and why the weight route is a different boxMounjaro is approved for type 2 diabetes in adults and children from 10, and Lilly's own site says it is not a weight-loss drug. With a diabetes diagnosis, any prescriber can write it and a commercial plan that covers it brings it to $25 with Lilly's card. Without diabetes, a prescriber can write it off-label, but no insurer will cover it and LillyDirect self-pay starts at $499 a month, against a list price of $1,112.16 per fill. The same tirzepatide in the Zepbound box is approved for weight, plan-coverable, and sold direct for $299 to $699.Buying safelyCompounded tirzepatide: what it is, what FDA says now the shortage is over, and what it costs against ZepboundCompounded tirzepatide is Zepbound's molecule made by a licensed pharmacy rather than Lilly, sold through telehealth programs from $85 a month on our board against Lilly's $299 to $699 ($449 on the KwikPen from 7.5 mg with on-time refills). It is not FDA-approved, and the legal ground under it has shifted: FDA says tirzepatide no longer appears on its shortage list, which was the condition that let pharmacies compound copies of an approved drug at scale. What remains is compounding for individual patients, FDA's list of specific concerns about how these products are dosed, shipped and labelled, and a price gap large enough that most cash buyers take the trade anyway. This page sets all of that out.Buying safelyHow much does Ozempic cost: $25 covered, $199 to $499 cash, and why the weight-loss version of the same drug is cheaperOzempic has four prices. With a commercial plan that covers it for type 2 diabetes, Novo's card brings it to $25 a month, capped at $100 of savings. Without coverage, Novo sells the pen direct for $199 a month for the first two fills if you are new, then $349 for 0.25, 0.5 and 1 mg and $499 for 2 mg, and a new Ozempic pill from $149. For weight loss, insurers refuse it because it is a diabetes drug, and Wegovy, the same semaglutide in the weight box, costs less from the same company. Compounded semaglutide starts at $69 on our board.Buying safelyHow much does Wegovy cost: the pen, the pill, insured, cash, Medicare and compounded, in one tableWegovy costs six different amounts depending on who is paying. A commercial plan that covers it brings it to $25 a month with Novo's card, capped at $100 of savings. Medicare covers it for $50 a month through the GLP-1 Bridge until the end of 2027. Cash, the pen is $349 a month at every dose, $199 for the first two fills if you are new, and $399 for the 7.2 mg HD pen; the pill is $149, $199 or $299 by strength. Compounded semaglutide, the same molecule without FDA approval, starts at $69 on our board. This page holds all six with their conditions and their sources.Buying safelyHow to get a GLP-1 covered by insurance, in the order it actually worksThere are four gates and most people fight the wrong one first. Before any clinical criterion applies, your employer has to have bought the weight-loss drug category at all, and if they did not, no BMI number and no comorbidity will change the answer. Once past that, the published criteria across the major insurers are strikingly consistent: BMI of 30 or more, or 27 with a weight-related condition, plus a documented period of lifestyle change, plus roughly 5 percent weight loss to stay approved at renewal.Buying safelyIs Hims legit? What its GLP-1 program costs, what reviews say, and its FDA recordYes. Hims & Hers is a real, licensed telehealth company, and as of October 2026 its weight-loss program sells FDA-approved brand-name GLP-1s: the Wegovy pill starts at $149 a month for the medication, plus a membership of $39 for the first month and $149 a month after, so about $298 a month from month two. It scores 2.9 on Trustpilot across 9,517 reviews, and FDA sent it a warning letter in September 2025 over compounded semaglutide marketing claims.Buying safelyIs Noom legit? What Noom's GLP-1 program costs, its reviews, and its recordYes. Noom is a real company, and its Noom Med arm prescribes GLP-1s through licensed clinicians. As of October 2026 its own site prices the medication-included Noom GLP-1Rx plan, which is compounded semaglutide, at $129 for the first four weeks, then $279 a month billed as $837 every 12 weeks, though the FAQ on the same page says $249. Trustpilot scores Noom 4.5 across 67,088 reviews, mostly about its app, and we found no FDA warning letter naming it.Buying safelyIs Henry Meds legit? What it charges, what reviews say, and its FDA recordYes. Henry Meds is a real telehealth company that prescribes compounded GLP-1s through licensed providers and, by its own account, fills them only at licensed US compounding pharmacies. As of October 2026 its plans start at $179 a month for compounded liraglutide or under-the-tongue semaglutide, and weekly semaglutide injections are $297 a month on its own price page. Trustpilot scores it 4.4 across 12,534 reviews, and we found no FDA warning letter naming it.Buying safelyIs Mochi Health legit? What it costs, what reviewers say, and its FDA recordYes. As of October 2026 Mochi Health is a real telehealth company: a licensed provider prescribes after a video visit, it publishes starting prices, it scores 4.5 on Trustpilot from 19,227 reviews, and FDA's warning-letter database lists no letter to it. It is not the cheap route. Membership is $79 a month after the first month, and medication is billed on top: compounded semaglutide from $60 a month and compounded tirzepatide from $90 at the starting dose.Buying safelyIs Calibrate legit? What the program costs, who it takes, and what reviewers sayYes. As of October 2026 Calibrate is a real, insurance-led GLP-1 program: clinicians prescribe branded drugs such as Wegovy and Zepbound, its site carries a LegitScript seal, it scores 4.5 on Trustpilot from 1,201 reviews, and FDA's warning-letter database lists no letter to it. It costs $199 a month with a 3-month minimum ($597), medication not included. It does not take anyone on Medicare, Medicaid or Tricare. Without drug coverage, it is an expensive route.Buying safelyGeneric Ozempic: none in the US until December 2031, where generics already sell, and what to buy insteadNo. There is no FDA-approved generic Ozempic or Wegovy in the US, and the FDA Orange Book lists Novo Nordisk's semaglutide compound patent until 5 December 2031. Generics went on sale in India in March 2026 and in Canada in May, but a US buyer cannot legally import them. What you can buy today: compounded semaglutide from $69 a month on our board, or Novo's own self-pay Wegovy at $349 a month for the pen and from $149 for the pill.Buying safelyHow much semaglutide costs: $69 compounded, $149 to $499 from Novo, $25 or $50 covered, by dose and by yearSemaglutide costs $69 to $299 a month compounded on our board, $149 to $299 for Novo's Wegovy pill, $349 for the Wegovy pen at any standard dose, and $349 or $499 for the Ozempic pen. With a commercial plan that covers it, Novo's card takes it to $25 a month; on Medicare, the GLP-1 Bridge charges $50. List price, before any discount, runs to $1,349.02 a box. Below: every route, the cost per dose and per mg, and the real yearly bill.Buying safelyIs LifeMD legit for weight loss? The program fee, the drug prices, and the reviewsYes. As of October 2026 LifeMD is a real telehealth company: affiliated licensed providers prescribe branded GLP-1s such as Wegovy and Zepbound, its pages carry a LegitScript seal, it scores 3.9 on Trustpilot from 4,270 reviews, and FDA's warning-letter database lists no letter to it. The catch is cost. The weight program is $39 for the first month and $149 a month after that. The drug is billed on top: Wegovy pen from $199, Zepbound vial from $299.Buying safelyYour GLP-1 was denied. Which kind of no was it?Three different things get called a denial and only two are worth appealing. If your plan excludes weight-loss drugs as a category, the refusal is not about you and no amount of clinical documentation moves it. If it is step therapy or unmet criteria, both are answerable, and the answer is usually documentation rather than argument. Here is how to tell which one you got, and what each needs.Buying safelyDo GLP-1 patches work? What the FTC and FDA say, and the real needle-free optionNo. No GLP-1 patch is FDA-approved, and the Federal Trade Commission's guidance is direct: "Nothing you can wear or apply to your skin will cause you to lose weight. Period." Patches sold as "GLP-1" are not semaglutide or tirzepatide, which are prescription drugs. If the appeal is avoiding needles, two approved GLP-1 pills exist: the Wegovy pill and Foundayo, both from $149 a month self-pay from their makers.Buying safelyIs compounded semaglutide safe? What FDA actually says, and what it does notCompounded semaglutide is the same molecule as Wegovy and Ozempic, made by a licensed pharmacy rather than Novo Nordisk, and it is lawful. What it is not is FDA-approved: in FDA's words, the agency "does not review compounded drugs for safety, effectiveness or quality before they are marketed". FDA's published concerns are specific, and none of them is that the molecule is different. They are dosing errors from self-measured vials, products shipped warm, fraudulent labels naming pharmacies that never made them, and doses above the approved label. Each is checkable before you buy, and this page shows how.Buying safelyHow to check a GLP-1 seller is legitimate, in about ten minutesYou can verify most of what matters yourself, and it takes about ten minutes. Look the company up on LegitScript, check the dispensing pharmacy's licence with the state board of pharmacy it names, confirm there is a real prescriber and a real prescription, find a physical address, and be suspicious of any price far below the market floor. We verify prices, fees, state coverage and reviews across every program we track and re-check them weekly. We do not audit pharmacies or test product, and any site telling you it does is worth a second look.Buying safelyHow to get prescribed a GLP-1, and what the label actually requiresAlmost every page on this says you need a BMI of 30, or 27 with a weight-related condition. Those numbers are not what the indication says. Wegovy's label describes adults with obesity, or adults with overweight and at least one weight-related comorbid condition, and it separately lists two routes most people have never heard of: reducing cardiovascular risk in adults with established cardiovascular disease, and treating MASH with moderate to advanced liver fibrosis. Whether you qualify is a clinical judgement, and it is a wider door than the BMI number suggests.
